Novartis Kisqali® reports longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients
![JCI Insight - Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial JCI Insight - Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial](https://df6sxcketz7bb.cloudfront.net/manuscripts/99000/99145/medium/jci.insight.99145.t3.jpg)
JCI Insight - Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
![Download Revlimid Dex Median Overall Survival In Non-transplant - Overall Survival PNG Image with No Background - PNGkey.com Download Revlimid Dex Median Overall Survival In Non-transplant - Overall Survival PNG Image with No Background - PNGkey.com](https://www.pngkey.com/png/full/359-3599597_revlimid-dex-median-overall-survival-in-non-transplant.png)
Download Revlimid Dex Median Overall Survival In Non-transplant - Overall Survival PNG Image with No Background - PNGkey.com
![Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas | SpringerLink Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-022-04066-9/MediaObjects/11060_2022_4066_Fig3_HTML.png)
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas | SpringerLink
Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases | Media - Cureus
![Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram](https://www.researchgate.net/publication/341170479/figure/fig2/AS:962781394255883@1606556380401/Kaplan-Meier-curves-for-overall-survival-The-median-overall-survival-was-180months-95.png)
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
![Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric Cancer in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 12 (2022) Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric Cancer in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 12 (2022)](https://jnccn.org/cover/journals/jnccn/20/12/cover.jpg)
Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric Cancer in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 12 (2022)
![Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-022-01845-z/MediaObjects/41416_2022_1845_Fig4_HTML.png)
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
![Current Oncology | Free Full-Text | Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer Current Oncology | Free Full-Text | Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer](https://www.mdpi.com/curroncol/curroncol-30-00151/article_deploy/html/images/curroncol-30-00151-g002.png)
Current Oncology | Free Full-Text | Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer
![NEJM on Twitter: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months NEJM on Twitter: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months](https://pbs.twimg.com/media/FJf6WueVIAMWHvU.jpg)
NEJM on Twitter: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
Kaplan-Meier survival curve comparing median overall survival between... | Download Scientific Diagram
![The Role and Clinical Effectiveness of Multiline Chemotherapy in Advanced Desmoplastic Small Round Cell Tumor - Hyehyun Jeong, Yong Sang Hong, Young-Hoon Kim, Chan Wook Kim, Si Yeol Song, Joon Seon Song, The Role and Clinical Effectiveness of Multiline Chemotherapy in Advanced Desmoplastic Small Round Cell Tumor - Hyehyun Jeong, Yong Sang Hong, Young-Hoon Kim, Chan Wook Kim, Si Yeol Song, Joon Seon Song,](https://journals.sagepub.com/cms/10.1177/1179554920987107/asset/images/large/10.1177_1179554920987107-fig2.jpeg)